Crossmark

Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy

Crossref DOI link: https://doi.org/10.1136/jitc-2020-000967

Published Online: 2020-07-15

Published Print: 2020-07

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Chuckran, Christopher A

Liu, Chang

Bruno, Tullia C

Workman, Creg J

Vignali, Dario AA
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct03565445 at ClinicalTrials.gov

Documents that mention this clinical trial

Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy
https://doi.org/10.1136/jitc-2020-000967
Funding

Funding for this research was provided by:

NCI Predoctoral Fellowship Award (F31 CA243168)

National Institutes of Health (P01 AI108545)

National Institutes of Health (R01 CA203689)
License Information

License valid from 2020-07-15